期刊文献+

人PRKAG2全长基因的体外拼接及TA克隆载体的构建 被引量:1

Gene Splicing and Construction of PRKAG2 Gene TA Cloning Vector
原文传递
导出
摘要 目的:应用体外基因拼接及TA克隆技术构建含PRKAG2基因的载体。方法:通过商业途径购得PRKAG2基因的一个转录变体cDNA质粒(GenBank登记号BC068598),其在N端缺失了44个氨基酸,根据已知的PRKAG2基因序列(GenBank登记号NM_016203),设计搭桥引物及序列扩增引物,通过PCR搭桥方法,合成完整全序列的PRKAG2基因,并将其克隆到TA载体,将得到的阳性克隆测序鉴定。结果:拼接出全长1759bp的PRKAG2基因,目的基因连接到载体后测序与设计的PRKAG2基因完全一致。结论:成功的构建了全长人PRKAG2基因的TA克隆,为进一步研究PRKAG2基因的功能提供了模板。 Objective: To obtain the complete sequence of PRKAG2 by gene splicing and construct the recombining vector of PRKAG2 gene by TA cloning technique. Methods: The incomplete PRKAG2 cDNA clone (GenBank accession number: BC068598), which lost 44 amino acids in N-end, was obtained by purchase. The PRKAG2 gene sequence was designed according to the known PRKAG2 gene sequence (GenBank accession number: NM_016203). The full-length PRKAG2 gene was acquired using the designed primers by PCR-based gene assembly method. The PCR product was inserted into TA cloning vector. Results: The full-length PRKAG2 gene was obtained. The TA cloning vector was identified with the restriction enzyme cutting and sequencing. Conclusion: The full-length PRKAG2 gene TA cloning vector was constructed successfully.
出处 《现代生物医学进展》 CAS 2009年第8期1465-1468,共4页 Progress in Modern Biomedicine
关键词 PRKAG2基因 基因拼接 TA克隆载体 PRKAG2 Gene splicing TA cloning vector
  • 相关文献

参考文献12

  • 1Stemmer WPC, Crameri A, Ha KD, et al. Single-step assembly of a gene and entire a plasmid from large numbers of oligodeoxyribonucleotides [J]. Gene, 1995, 164(1):49-53
  • 2Cherry J, Nieuwenhuijsen BW, Kaftan EJ, et al. A modified method for PCR-directed gene synthesis from large number of overlapping oligodeoxyribonueleotides [J]. J Biochem Biophys Methods, 2008,70 (6):820-822
  • 3Naderi-Manesh H, Ranjbar B, Maroufi B, et al. PCR-based gene synthesis, molecular cloning, high level expression, purification, and characterization of novel antimicrobial peptide, brevinin-2R, in Escherichia coli [J]. Appl Biochem Biotechnol, 2008, 149(2): 109-118
  • 4Gao X X, Yo P, Keith A, et al. Thermodynamically balanced inside-out (TBIO) PCR-based gene synthesis: a novel method of primer design for high delity assembly of longer gene sequences [J]. Nucleic Acids Res, 2003, 31(22):143
  • 5Bayrak F, Komurcu-Bayrak E, Mutlu B, et al. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation [J]. Eur J Heart Fail, 2006, 8(7):712-715
  • 6Laforet P, Richard P, Said MA, et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis [J]. Neuromuscul Disord, 2006, 16 (3):178-182
  • 7Davies JK, Wells DJ, Liu K, et al. Charaeterisation of the role of the γ 2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome [J]. Am J Physiol Heart Circ Physiol, 2006, 290(5):H1942-1951
  • 8Jason R.B.Dyck, Gary D. Lopaschuk. AMPK alterations in cardiac physiology and pathology: enemy or ally [J]. J Physiol, 2006, 574(Pt 1):95-112
  • 9Banerjee SK, Ramani R, Saba S, et al. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia [J]. Biochem Biophys Res Commun, 2007, 360(2): 381-387
  • 10Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice over expressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy [J]. Circulation, 2003, 107(22): 2850-2856

同被引文献12

  • 1张静,郑兴,秦永文,周炳炎,吴弘,王洪如.家族性传导系统异常伴心室预激及心肌肥厚一家系调查分析[J].中华心血管病杂志,2007,35(3):258-259. 被引量:9
  • 2洪葵,Antonio Oliva,程晓曙,Pedro Brugada,Joseph Brugada,Eduardo-back Sternick,Ramon Brugada.相同基因型而不同表现型的PRKAG2基因突变一家系报道[J].中华心血管病杂志,2007,35(6):552-554. 被引量:9
  • 3Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease [J]. Circ Res, 2007; 100 (4): 474-488.
  • 4Gollob MH, Green MS, Tang ASL, et al. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy [J]. Curr Opin Cardiol, 2002; 17(3 ): 229-234.
  • 5Gollob MH, Green MS, Tang ASL, et al. PRKAG2 cardiac syndrome: familial ventricular preexcitation conduction system disease, and cardiac hypertrophy [J]. Curt Opin Cardiol, 2002; 17(3): 229-234.
  • 6Mark CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J]. J Thorac Cardiovasc Surg, 1998, 115: 168-177.
  • 7Brody SL, Crystal RG, Boris-Lawrie K, et al. Adenovirus-mediated in vivo gene transfer [J]. Ann NY Acad Sci11997, 716: 90-103.
  • 8Flugelman MY, Jaklitsch MT, Newman KD, et al. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter [J]. Circ, 1992, 85:1110-1117.
  • 9Riessen R, Rahimizadeh H, Takeshita S, et al. Successful vascular gene transfer using a hydrogel coated balloon angioplasty catheter [J]. Hum Gene Ther, 1993, 4:749-758.
  • 10Landy A. Dynamic, Structural, and regulatory aspects of lambda site-specific recombination [J]. Annu Rev Biochem, 1989, 58: 913-949.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部